T-cell lymphoblastic lymphoma
Clinical trials for T-cell lymphoblastic lymphoma explained in plain language.
Never miss a new study
Get alerted when new T-cell lymphoblastic lymphoma trials appear
Sign up with your email to follow new studies for T-cell lymphoblastic lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
A pill after transplant: new hope to stop t-cell cancer relapse
Disease control Not yet recruitingThis trial tests whether taking chidamide, an oral drug, after a stem cell transplant can lower the chance of the cancer coming back in people with high-risk T-cell acute lymphoblastic leukemia or lymphoma. Participants are randomly assigned to receive chidamide for up to 24 mont…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase 3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Experimental CAR-T therapy targets tough childhood blood cancers
Disease control Not yet recruitingThis early-phase trial is testing a new treatment called PA3-17 injection for children and teens aged 3 to 18 with T-cell leukemia or lymphoma that has not responded to standard therapy or has come back. The treatment uses the patient's own immune cells, modified to recognize and…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase 1 • Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC